About Tenet Healthcare (NYSE:THC)

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company's segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children's hospitals, two specialty hospitals and one critical access hospital. The Company's Ambulatory Care segment includes the operations of its USPI joint venture and its Aspen facilities. As of December 31, 2016, Conifer provided one or more of the business process services described above from 20 service centers to more than 800 Tenet and non-Tenet hospital and other clients in over 40 states. As of December 31, 2016, the Company operated 20 short-stay surgical hospitals, over 470 outpatient centers, and nine facilities in the United Kingdom.

Receive THC News and Ratings via Email

Sign-up to receive the latest news and ratings for THC and its competitors with MarketBeat's FREE daily newsletter.

Profitability

Miscellaneous

Tenet Healthcare (NYSE:THC) Frequently Asked Questions

What is Tenet Healthcare's stock symbol?

Tenet Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "THC."

How were Tenet Healthcare's earnings last quarter?

Tenet Healthcare Corp (NYSE:THC) issued its quarterly earnings results on Monday, November, 6th. The company reported ($0.17) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.40) by $0.23. The company earned $4.59 billion during the quarter, compared to analyst estimates of $4.94 billion. Tenet Healthcare had a negative net margin of 2.85% and a negative return on equity of 5.61%. Tenet Healthcare's quarterly revenue was down 5.4% compared to the same quarter last year. During the same period last year, the business earned $0.16 EPS. View Tenet Healthcare's Earnings History.

When will Tenet Healthcare make its next earnings announcement?

What guidance has Tenet Healthcare issued on next quarter's earnings?

Tenet Healthcare issued an update on its FY18 earnings guidance on Tuesday, December, 19th. The company provided earnings per share guidance of $1.07-1.36 for the period, compared to the Thomson Reuters consensus estimate of $1.38. The company issued revenue guidance of $17.8-18.2 billion, compared to the consensus revenue estimate of $18.61 billion.

Where is Tenet Healthcare's stock going? Where will Tenet Healthcare's stock price be in 2018?

14 brokerages have issued twelve-month price objectives for Tenet Healthcare's shares. Their forecasts range from $14.00 to $27.00. On average, they anticipate Tenet Healthcare's stock price to reach $18.15 in the next year. View Analyst Ratings for Tenet Healthcare.

What are Wall Street analysts saying about Tenet Healthcare stock?

Here are some recent quotes from research analysts about Tenet Healthcare stock:

1. According to Zacks Investment Research, "Tenet Healthcare’s shares have underperformed the industry in a year's time. The company has a high level of uncollectible accounts leading to mounting level of bad debt. Rising level of debt has led to a spike in interest expenses, weighing on margins. The company has also been suffering from lower revenues over past many quarters. Tenet Healthcare has also seen its Zacks Consensus Estimate for 2018 earnings being revised downward in the past 60 days. Following lackluster third-quarter 2017 results, the company lowered its guidance for 2017. The company has also lowered its 2018 earnings guidance following the recent tax cut. However, accretive acquisitions have significantly strengthened the top line. Strategic divestitures helped streamline its core operations. Moreover, the company’s recently taken enterprise-wide cost reduction program is likely to favor earnings going forward." (1/20/2018)

2. Mizuho analysts commented, "Part of the job of an analyst is to connect disparate pieces of information in order to validate, reject or create an investment thesis. We connect THC's January comments about cost cutting initiatives & potential asset sales with reports from Detroit & other markets regarding the possible depth, immediacy and impact of those cuts, CYH's recent success with the same strategy and then estimate the potential impact on EBITDA and valuation. The conclusion we reach is that our Underperform rating was no longer valid. We raise our rating to Neutral and our PT to $22.80 from $13." (2/24/2017)

Are investors shorting Tenet Healthcare?

Tenet Healthcare saw a decline in short interest during the month of January. As of January 31st, there was short interest totalling 24,900,579 shares, a decline of 15.3% from the January 12th total of 29,410,207 shares. Based on an average trading volume of 2,810,713 shares, the short-interest ratio is currently 8.9 days. Currently, 25.3% of the company's shares are short sold.

How do I buy Tenet Healthcare stock?

Shares of Tenet Healthcare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tenet Healthcare's stock price today?

One share of Tenet Healthcare stock can currently be purchased for approximately $19.38.

How big of a company is Tenet Healthcare?

Tenet Healthcare has a market capitalization of $1.96 billion and generates $19.62 billion in revenue each year. The company earns $-192,000,000.00 in net income (profit) each year or ($5.50) on an earnings per share basis. Tenet Healthcare employs 131,610 workers across the globe.

How can I contact Tenet Healthcare?

Tenet Healthcare's mailing address is 1445 Ross Ave Ste 1400, DALLAS, TX 75202-2703, United States. The company can be reached via phone at +1-469-8932200 or via email at [email protected]

MarketBeat Community Rating for Tenet Healthcare (THC)

MarketBeat's community ratings are surveys of what our community members think about Tenet Healthcare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Tenet Healthcare (NYSE:THC) Analysts' Consensus Rating

MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.

MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.